Aspen could produce 10-million dexamethasone tablets within a month, CEO says
Results from a trial showed that dexamethasone reduced death rates by about a third
23 June 2020 - 21:01
Pharmaceutical manufacturer Aspen could provide 10-million dexamethasone tablets within a month, CEO Stephen Saad said on Tuesday.
Results from a trial showed that dexamethasone reduced death rates by about a third compared with a placebo in severely ill hospitalised Covid-19 patients, University of Oxford scientists said last week, calling the discovery a major breakthrough...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.